CRH Medical Corp (CRHM) Rating Reiterated by RBC Capital Markets
CRH Medical Corp (NASDAQ:CRHM)‘s stock had its “outperform” rating reiterated by stock analysts at RBC Capital Markets in a report released on Saturday. They presently have a $6.50 target price on the stock. RBC Capital Markets’ price objective would suggest a potential upside of 50.46% from the company’s current price.
Several other equities research analysts have also issued reports on the stock. Canaccord Genuity reissued a “buy” rating on shares of CRH Medical Corp in a research report on Thursday, June 30th. CIBC reissued an “outperform” rating on shares of CRH Medical Corp in a research report on Tuesday, September 13th. Finally, Zacks Investment Research lowered shares of CRH Medical Corp from a “buy” rating to a “hold” rating in a research report on Monday, September 5th.
Shares of CRH Medical Corp (NASDAQ:CRHM) opened at 4.32 on Friday. CRH Medical Corp has a 12 month low of $2.15 and a 12 month high of $4.39. The company has a 50-day moving average of $3.80 and a 200-day moving average of $3.55.
Large investors have recently added to or reduced their stakes in the stock. Hillsdale Investment Management Inc. purchased a new stake in CRH Medical Corp during the second quarter worth $3,661,000. Stifel Financial Corp purchased a new stake in CRH Medical Corp during the second quarter worth $3,051,000. Mackenzie Financial Corp purchased a new stake in CRH Medical Corp during the second quarter worth $1,899,000. Counsel Portfolio Services Inc. purchased a new stake in CRH Medical Corp during the second quarter worth $485,000. Finally, Sentry Investments Corp. raised its stake in CRH Medical Corp by 1.9% in the second quarter. Sentry Investments Corp. now owns 386,300 shares of the company’s stock worth $1,943,000 after buying an additional 7,300 shares during the last quarter.
CRH Medical Corp Company Profile
CRH Medical Corporation, formerly Medsurge Medical Products Corp., is a healthcare products and services company. The Company operates through segments, including the sale of medical products and the provision of anesthesia services. The Company specializes in the treatment of hemorrhoids utilizing its treatment protocol and technology.
Receive News & Stock Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related stocks with our FREE daily email newsletter.